Abstract: A method for selectively controlling the rate of release of a liposome-entrapped compound from an intramuscular or subcutaneous injection site. The method includes selecting the average size, amount, and lipid composition of liposomes injected into the site to produce a desired half-life of release of the compound. A preferred composition used in practicing the invention includes an aqueous suspension of liposomes containing the compound in entrapped form, and having average particle sizes less than about 0.2 microns, and large amount of larger empty lipsomes present in an amount effective to increase the half-life of release of the compound from the injection site to a desired half-life between about 1-14 days.
Abstract: Transdermal flux enhancers such as oleic acid and 1-dodecylazacycloheptan-2-one are used in combination with iontophoresis in the topical administration of pharmaceutical agents.
Abstract: This invention presents novel two-phase hair-fixing aerosol systems which are aqueous-based. The systems, which utilize dimethyl ether as a propellant (and also a solvent, as needed), can be shaken to form a semi-stable emulsion or mixture which is stable for a time sufficient for spraying, and are compatible with a wide variety of hair-fixing resins.
Type:
Grant
Filed:
September 18, 1989
Date of Patent:
June 4, 1991
Assignee:
National Starch and Chemical Investment Holding Corporation
Abstract: The invention is related to solid drug preparations of 2-phenyl-1,2-benzisoselenazol-3(2H)-one (EBSELEN) with high bioavailability comprising EBSELEN in the form of micronized crystals, and a method of manufacturing the same.
Abstract: Disclosed is a biocompatible, thromboresistant substance useful for implantable and extracorporeal devices in contact with the vascular system, and methods for producing the same. The biocompatible, thromboresistant substance comprises a synthetic, biocompatible material, at least one biocompatible base coat layer adhered to at least one surface of the material, and a thrombogenesis inhibitor immobilized on the base coat layer via a component capable of binding the inhibitor. The thrombogenesis inhibitor is streptokinase, urokinase, tissue plasminogen activator, ATPase, 5'-nucleotidase, and active fragments and active analogs thereof.
Type:
Grant
Filed:
August 3, 1988
Date of Patent:
May 28, 1991
Assignee:
New England Deaconess Hospital Corporation
Abstract: A class of unsaturated polyanhydrides having double bonds available for secondary polymerization is disclosed. A crosslinked material having improved or different physical and mechanical properties can be prepared from these polyanhydrides, via secondary polymerization. The synthesis and characteristics of one unsaturated polyanhydride based on fumaric acid and its copolymers with aliphatic and aromatic diacids, prepared by either the melt-polycondensation method or by solution polymerization, is described in detail.These polymers are well suited for use in controlled release drug delivery devices. The polymers can also be used as a bioerodible bone cement where the polymer is first cast as a solution onto a bone fracture and then crosslinked by radiation or radical polymerization to yield a strong, adhesive material.
Abstract: Novel compositions of matter are provided herein which are the reaction product of polyvinylpyrrolidone and hypochlorites. These compositions are useful as antimicrobial agents.
Abstract: Penetration of various drugs through living membranes is improved by their use in transdermal compositions containing certain penetration-enhancing systems. A new delivery device is also described.
Type:
Grant
Filed:
August 9, 1989
Date of Patent:
May 28, 1991
Assignee:
Warner-Lambert Company
Inventors:
Majid Mahjour, Bernadette Mauser, Zahra Rashidbaigi, Edwards E. Linn
Abstract: A protective gel composition is disclosed for coating skin surfaces, particularly the hands of the surgical attendants prior to covering the hands with standard surgical gloves. In one example, the composition comprises controlled proportions in mixture by weight of lanolin, a liquid silicone, polypropylene glycol mono-oleate, polytetrafluoroethylene powder in microspherical form and zinc oxide powder. Anti-microbial and anti-viral agents may be further added to fortify the coating of the composition, with a preferred such agent being nonoxynol-9. The sterilized composition is applied to the hands after scrubbing and just prior to insertion into the gloves. The coating is water-repellent to prevent skin contact with body fluids, such as blood and blood products, that may penetrate the gloves and otherwise expose the skin to harmful microbial and viral infections. When the gloves are removed following the surgical procedure, the coating is easily removed with an alcohol and liquid detergent wash.
Abstract: The object of the invention is a tablet sustaining release for more than 8 hours, the active ingredient of which is constituted by the complex formed between one mole of valproic acid and one mole of sodium valproate.
Abstract: This invention relates to cationic oil-in water emulsion compositions which are especially useful as hair conditioning compositions which have a sparkling pearlescent appearance due to the presence of irregular platelet-like crystals suspended in the composition. The compositions comprise a cationic water-in-oil emulsion of from (a) about 0.1% to 5%, preferably from 0.1 to 0.8%, of a quaternary ammonium compound such as stearyl dimethyl benzyl ammonium chloride; (b) about 1-10%, preferably 1-2%, of a fatty acid having 12-16 carbon atoms such as myristic acid and a fatty monoalcohol having from 12 to 18 carbon atoms such as cetyl alcohol in a 70:30 to 95:5, preferably 75;25 to 85:15, weight ratio of acid to alcohol; (c) about 0.
Abstract: Novel aluminum and aluminum-zirconium salts are produced by reacting aluminum or aluminum-zirconium halohydrate with an anionic lipophilic component. These salts are useful in antiperspirant compositions or as rheological additives. Also disclosed is a novel process of producing oil-in-water emulsions whereby the novel aluminum or aluminum-zirconium salt functions as a surfactant upon forming.
Abstract: The invention serves to prevent or delay the formation of undesired phosphine levels in packages in which phosphine releasing compositions (in particular hydrolysable metal phosphides) are packaged and stored and in environments to be fumigated during the period of introduction of phosphine-releasing compositions. This is brought about by maintaining in the immediate vicinity of the composition a zeolite having a pore width from 0.3 nm upwards, preferably 0.4 to 1.5 nm and an adsorbtive affinity for moisture or phosphine or preferably both. The zeolite is employed either as a separate item in the package or as part of the composition, admixed or as a coating. In a mass ratio of metal phosphide to zeolite are from 1:0.05 to 1:2. The adsorption of phosphine to the zeolite is reversible and on exposure to an environment to be subjected to pest control, the zeolite will release the adsorbed phosphine by replacement by atmospheric humidity.
Abstract: The edible baked composition delivers cholestyramine in a palatable, pleasant tasting form. Embodiments include a nutrition bar and a cookie. The composition is useful for the control of endogenous cholesterol levels in humans.
Abstract: Antigenic parasites are encapsulated in semipermeable polymeric envelope membranes to prepare implant capsules for immunizing an animal against parasitic infection. An animal may be immunized against parasitic infection by implanting into the animal the implant capsule at a location in the animal sufficient to stimulate a protective immune response in the animal to the parasite antigen.
Type:
Grant
Filed:
August 11, 1989
Date of Patent:
May 14, 1991
Assignee:
Paravax, Inc.
Inventors:
Kent C. Cochrum, Lynnor B. Stevenson, Scott R. King
Abstract: Trash bags and other products from LLDPE are made animal repellent by incorporation of terpene in the LLDPE in the melt process for fabricating such products from the polymer.
Abstract: Dextrorphan salts with polycarboxylic organic acids are effectively absorbed by the oral route and can conveniently be formulated in pharmaceutical compositions suitable to the oral administration.
Type:
Grant
Filed:
September 12, 1989
Date of Patent:
May 7, 1991
Assignee:
Prodotti Formenti s.r.l.
Inventors:
Carlos Passarotti, Antonio Fossati, Mauro Valenti, Gianluigi Bandi
Abstract: Improved delayed release pharmaceutical dosage unit forms such as tablets are obtained by exposing a matrix of a compressed mixture of active pharmaceutical ingredient and of a polyacrylic ester polymer or a vinyl ester polymer insoluble in body fluids at the point of release to vapors of a lower alcohol.
Abstract: A matrix for delivery of active substances such as fragrances and pheromones into the atmosphere is provided which matrix is active substance permeable (including to hydrophilic substances) and is formed of a copolymer which can be softened sufficiently at temperature between 45.degree. C. and 160.degree. C. to incorporate the substances therein without damage caused by heat or chemical reactions, the matrix being formed of a substantially linear block copolymer which is a reaction product of a polydiorganosiloxane which forms soft segments in said reaction product and a diisocyanate which forms hard segments, said copolymer having a glass transition temperature between 45.degree. C. and 160.degree. C. said soft segments comprising from 70 to 99 percent by weight, based on the weight of said copolymer, the average molecular weight of the copolymer being between 15,000 and 500,000.
Abstract: Cellulose derivatives are disclosed which have the following formula: ##STR1## wherein Z is selected from the group consisting of alkylene, alkenylene, alkynylene, cycloalkylene or benzylene or xylylene radicals, which may or may not be substituted;X is selected from the group consisting of --H, --NR.sub.2, --N.sup.+ R.sub.3, --CN, --COOH, --SO.sub.3 H, --SO.sub.3 H, --PO(OR).sub.2, CONR.sub.2 or --Si(OR).sub.3 ;R is selected from the group consisting of hydrogen, alkyl and alkenyl groups having from 1 to 25 carbon atoms, and cycloalkyl, tolyl and phenyl groups;Y is selected from the group consisting of alkyl, alkenyl, alkynyl groups having from 1 to 36 carbon atoms, which may or may not be substituted, cycloalkyl, phenyl, tolyl and benzyl groups, ##STR2## (--CH.dbd.CH--COOH), and NHR, where R has the same meaning as in X, andm=0 to 2.5n=0.01 to 2.95,with the provision that, when m=0, n.gtoreq.1.55, if Y is an alkyl radical with 1 to 5 carbon atoms, 3-(CH.sub.2).sub.